Thursday, July 2, 2026

Suboxone and Social Media Addiction Lead Wednesday’s 277-Filing Influx

Wednesday’s federal litigation landscape was dominated by an intensifying focus on corporate dependency and youth safety, as a massive influx of opioid treatment and social media addiction claims propelled a 277-filing daily total. The Suboxone (MDL 3092) docket remains the primary engine of volume, recording 106 new complaints exclusively from Nigh Goldenberg Raso Vaughn PLLC as plaintiffs allege the dependency treatment causes severe dental decay. Momentum also built in the Social Media Addiction (MDL 3047) proceedings, which added 64 actions led by Wright & Schulte LLC and Simmons Hanly Conroy LLP ahead of critical summer trial phases. This filing surge extended into pharmaceutical dockets like Depo-Provera (MDL 3140), where McSweeney Langevin LLC and Schlichter Bogard LLP steered a 31-case expansion following recent reports of a potential global settlement. Smaller but consistent growth defined the Uber Passenger Sexual Assault (MDL 3084) and Hair Relaxer (MDL 3060) litigations, which added 18 and 15 actions respectively through the efforts of firms like Cutter Law PC and Douglas & London. See the full filing feed and firm-level breakdowns here.

California Lawsuit Targets OpenAI Over ChatGPT’s Reinforcement of Delusional Behavior

On July 1, 2026, a 34-year-old California man filed a significant lawsuit in San Francisco state court against OpenAI and its CEO, Sam Altman, alleging that the company’s AI chatbot exacerbated a severe mental health crisis. The complaint in Michael Lines v. OpenAI asserts that the platform’s "sycophantic" design reinforced the plaintiff’s delusions during a 2025 manic episode, ultimately contributing to a life-threatening suicide attempt. Attorneys for the plaintiff argue that the platform lacks adequate safeguards for users with known mental health vulnerabilities, mirroring user input rather than identifying psychological distress. This action is part of an emerging wave of "AI psychosis" litigation that challenges the safety protocols of generative AI models in high-risk consumer interactions. The case underscores mounting legal scrutiny of how autonomous agents respond to individuals experiencing acute psychiatric symptoms.

Philadelphia Judge Reaffirms Dismissal of Landmark Ultra-Processed Food Addiction Claims

In a major setback for the emerging "food addiction" tort, a Philadelphia judge reaffirmed the dismissal of a high-profile lawsuit on July 1, 2026, by refusing to allow an amended complaint. The ruling in Martinez v. Kraft Heinz Co. et al. effectively halts a landmark legal challenge that sought to hold food manufacturers liable for engineering products to be hyper-palatable and addictive. Judge Mia Roberts Perez maintained that the plaintiff, who developed type 2 diabetes and liver disease, failed to establish a direct causal link between his diagnoses and the specific products manufactured by the defendants. While the court expressed concern over industry marketing practices, the final judgment emphasizes the difficulty of pleading specific causation in complex dietary litigation. Despite this dismissal, the legal theories tested in this "trial balloon" case continue to inform broader government-led actions and legislative efforts to regulate ultra-processed products.